Annual Retained Earnings
-$316.97 M
-$176.94 M-126.35%
December 31, 2023
Summary
- As of February 26, 2025, NAMS annual retained earnings is -$316.97 million, with the most recent change of -$176.94 million (-126.35%) on December 31, 2023.
- During the last 3 years, NAMS annual retained earnings has fallen by -$309.50 million (-4140.78%).
- NAMS annual retained earnings is now -4140.78% below its all-time high of -$7.47 million, reached on December 1, 2020.
Performance
NAMS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$466.39 M
-$16.65 M-3.70%
September 30, 2024
Summary
- As of February 26, 2025, NAMS quarterly retained earnings is -$466.39 million, with the most recent change of -$16.65 million (-3.70%) on September 30, 2024.
- Over the past year, NAMS quarterly retained earnings has stayed the same.
- NAMS quarterly retained earnings is now -2350.76% below its all-time high of $20.72 million, reached on June 30, 2022.
Performance
NAMS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NAMS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -126.3% | 0.0% |
| 3 y3 years | -4140.8% | -233.1% |
| 5 y5 years | -4140.8% | -233.1% |
NAMS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -707.4% | at low | -2350.8% | at low |
| 5 y | 5-year | -4140.8% | at low | -2350.8% | at low |
| alltime | all time | -4140.8% | at low | -2350.8% | at low |
NewAmsterdam Pharma Company NV Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$466.39 M(+3.7%) |
| Jun 2024 | - | -$449.75 M(+9.5%) |
| Mar 2024 | - | -$410.74 M(+29.6%) |
| Dec 2023 | -$316.97 M | -$316.97 M(+50.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$211.33 M(+50.9%) |
| Dec 2022 | -$140.04 M(+256.7%) | -$140.04 M(-775.8%) |
| Jun 2022 | - | $20.72 M(-152.8%) |
| Dec 2021 | -$39.26 M(+425.3%) | -$39.26 M |
| Dec 2020 | -$7.47 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual retained earnings?
- What is the all time high annual retained earnings for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual retained earnings year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly retained earnings?
- What is the all time high quarterly retained earnings for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly retained earnings year-on-year change?
What is NewAmsterdam Pharma Company NV annual retained earnings?
The current annual retained earnings of NAMS is -$316.97 M
What is the all time high annual retained earnings for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual retained earnings is -$7.47 M
What is NewAmsterdam Pharma Company NV annual retained earnings year-on-year change?
Over the past year, NAMS annual retained earnings has changed by -$176.94 M (-126.35%)
What is NewAmsterdam Pharma Company NV quarterly retained earnings?
The current quarterly retained earnings of NAMS is -$466.39 M
What is the all time high quarterly retained earnings for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly retained earnings is $20.72 M
What is NewAmsterdam Pharma Company NV quarterly retained earnings year-on-year change?
Over the past year, NAMS quarterly retained earnings has changed by $0.00 (0.00%)